Kronos Bio, Inc. Profile Avatar - Palmy Investing

Kronos Bio, Inc.

Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks th…

Biotechnology
US, San Mateo [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Kronos Bio, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Kronos Bio, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Kronos Bio, Inc..

End of KRON's Analysis
CIK: 1741830 CUSIP: 50107A104 ISIN: US50107A1043 LEI: - UEI: -
Secondary Listings
KRON has no secondary listings inside our databases.